Japanese conveyor-belt sushi chain Sushiro has been building a strong following in China despite Beijing's total ban on ...

Bureaucracy, aversion to risk, high taxes are blamed for why Japan lags behind in the start-up scene. Read more at ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

The other night, I treated myself to dinner from my favorite sushi spot (my go-to order: spicy tuna roll, salmon-cucumber roll and miso soup). While I was eating, I found myself wondering—and ...

Dai-ichi Life Holdings (DCNSF – Research Report) received a Hold rating and a Yen4,900.00 price target from Jefferies analyst Sam Wong on March 7. The company’s shares closed last Friday at ...

Feb 28 (Reuters) - The European Union's health regulator on Friday backed AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab drug Enhertu as a breast cancer treatment ...